Image Analysis Group, Imaging Experts to Support Clinical Trials

NEWS

Dr Kubassova named one of the UK’s Most Ambitious Business Leaders

Recognized by the Times and LDC, London, 10 October 2024

IAG are Attending SCOPE Europe, Barcelona, 29-30 Oct

Meet our team at SCOPE Europe, 29-30 October 2024.

IAG are Presenting at the Premier Meeting for Spine Research

Meet Dr Carrino at NASS 39th Annual Meeting, September 25-28, 2024, Chicago, IL.

IAG Unveils Advanced AI Histology Tool for Clinical Research

Meet IAG at UEG and Scope 2024 to discuss imaging in your clinical trials.

IAG’s Experts Attend Osteoarthritis Imaging Meeting

Meet IAG at ISOAI meeting, Marrakech, Morocco, June 24-26, 2024.

Meet IAG’s Oncology Expert Team at ASCO, Chicago

Meet our expert oncology team at ASCO’24!

Just published: AI Scoring System for Histology Review in Ulcerative Colitis

Published in April 2024 in United European Gastroenterol Journal,

Meet IAG at DDW 2024: AI and Precision Medicine in Ulcerative Colitis

Digestive Disease Week (DDW) meeting, Washington 18-21 May 2024

VIEWS

Embracing Digital Innovation in Digestive Disease Drug Development

Share IAG’s experience in using Medical Imaging and A.I. in early and late phase clinical trials.

The Transformative Power of AI in Oncology Drug Development

Share IAG’s experience in using Medical Imaging and A.I. in early and late phase clinical trials.

Bone Health: New Drugs vs New Tools

The field of bone health is undergoing unprecedented advancements, with novel imaging techniques deployed to take novel platforms through approvals.

Cartilage Repair: Imaging in Treatment Advancements

Critical Role of Imaging is Crucial in Drug Development

Getting approval: the EMA and the FDA

Thinking through drug approval: the FDA and EMA and their requirements.

Imaging Power in Alzheimer’s Disease (AD) Studies

Breakthroughs in AD research and trials rely on accurate imaging and its interpretation.

A Story started by our President, Dr Olga Kubassova

While studying for her PhD at Leeds, UK Olga Kubassova began work on commercialising her research.

BioTech Investing in 2022, Jefferies Conference Reflections

The world saw unprecedented growth in healthcare investing in 2021.

IAG, Image Analysis Group
Leading imaging Clinical Research Organization that combines medical and operational expertise with cutting-edge proprietary A.I. capabilities to power drug development.
IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to III imaging trials across multiple indications.
We enhance the value and market potential of novel therapeutic assets, reduce risks of R&D and strategic investments, as demonstrated through successful pharmaceutical partnerships.

Planning a trial and would like to learn more about IAG and DYNAMIKA?

Email: imaging.experts@ia-grp.com

to discuss your
* clinical trial design and protocol development
* site selection and their capabilities
* imaging for screening and efficacy
* imaging data management
* patient concent to use data for AI
DYNAMIKA, Image Management Platform
Our team helps to optimise imaging studies by leveraging our in-house radiology expertise in the design and execution of trials, and through our cutting-edge DYNAMIKA platform, which allows for effective imaging data management, supported site workflow and accelerated patient recruitment. DYNAMIKA supports seamless data collection, real-time image Quality Control and central review. DYNAMIKA brings AI / ML into trial process to allow for a fully transparent data management, trial execution control and central review.
Global Client Services: Clinical Trials
At IAG, we help drug developers to effectively use imaging endpoints to accelerate drug development and lower investment risks into R&D.
Whether you are entering a phase I-III and need early robust efficacy data or planning an A.I. powered innovation project, our science, operations, and technology teams will work with you to develop the right solution.